You are here: All Products > BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal
BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal
You are here: All Products > BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal